Product Information
MECLIZINE 12.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0313 per EA under NDC 57237033301. Its NADAC has been published 68 times since Jun 18, 2025.
The High Outlier badge above means this manufacturer's average price in the MECLIZINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237033301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MECLIZINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M009.50On Market Since
7/22/2024
Pharmacological Classes
Price Statistics
The NADAC for MECLIZINE 12.5 MG TABLET has been published 68 times since Jun 18, 2025, and over the history we have for it it has risen 13.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0313 per EA |
|---|---|
| All-time high | $0.0357 (Oct 15, 2025) |
| All-time low | $0.0277 (Jun 18, 2025) |
| 52-week high | $0.0357 |
| 52-week low | $0.0294 |
| Median price | $0.0306 |
| Average price | $0.0311 |
| Largest weekly change | +17.9% (Jul 23, 2025) |
| Weeks tracked | 68 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
MECLIZINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiemetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MECLIZINE 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MECLIZINE 12.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0313 per EA (NDC 57237033301), effective Sep 30, 2026.
How has the price of MECLIZINE 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for MECLIZINE 12.5 MG TABLET has risen 13.0%. It has been tracked across 68 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for MECLIZINE 12.5 MG TABLET?
Since Jun 18, 2025, the NADAC for MECLIZINE 12.5 MG TABLET has ranged from a low of $0.0277 (Jun 18, 2025) to a high of $0.0357 (Oct 15, 2025), with a median of $0.0306 per EA.
Are there cheaper alternatives to MECLIZINE 12.5 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MECLIZINE 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MECLIZINE 12.5 MG TABLET?
MECLIZINE 12.5 MG TABLET (NDC 57237033301) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.